Hariharan Venkatesan

Author

Johnson & Johnson (United States)

Also Known As

C. Milligan, H Venkatesan, H. Venkatesan, Hariharan Venkatesan, Harshni Venkatesan

Publications

814

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Janssen (United States)Colorado State University Springhouse

About

Hariharan Venkatesan is an author at Johnson & Johnson (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	301
2	Biochemistry	6	6	223
3	Natural Sciences	5	5	211
4	Engineering	2	2	78
5	Arts	1	1	11

Hariharan Venkatesan

Publications

781

Citations

H-Index

Page 1

	Year	Citations
Total Synthesis of SR 121463 A, a Highly Potent and Selective Vasopressin V<sub>2</sub>Receptor Antagonist Hariharan Venkatesan, Matthew C. Davis, Yeşim Altaş, The Journal of Organic Chemistry	2001	130
DNA Damage Induced via 5,6-Dihydrothymid-5-yl in Single-Stranded Oligonucleotides Marc M. Greenberg, Mark R. Barvian, Gary P. Cook, Journal of the American Chemical Society	1997	75
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains John J. M. Wiener, Laurent Gomez, Hariharan Venkatesan, Bioorganic & Medicinal Chemistry Letters Sar DevelopmentMedicineTetrahydroindazole InhibitorsMultidrug-resistant StrainsPharmacotherapy	2007	73
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Molecular Pharmacology	2011	72
Improved Utility of Photolabile Solid Phase Synthesis Supports for the Synthesis of Oligonucleotides Containing 3‘-Hydroxyl Termini Hariharan Venkatesan, Marc M. Greenberg The Journal of Organic Chemistry Photolytic CleavageSolid Phase SupportEngineeringBiochemistryPhotochemistry	1996	67
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier, ACS Medicinal Chemistry Letters Erythropoietin SecretionPharmacotherapyRedox BiologyOxidative StressSystems Pharmacology	2010	62
A One-Step Synthesis of 2,4-Unsubstituted Quinoline-3-carboxylic Acid Esters from <i>o</i>-Nitrobenzaldehydes Hariharan Venkatesan, Frances M. Hocutt, Todd K. Jones, The Journal of Organic Chemistry	2010	45
Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation‐induced anaemia in rats Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, British Journal of Pharmacology	2015	43
Identification and Optimization of Anthranilic Sulfonamides as Novel, Selective Cholecystokinin-2 Receptor Antagonists Brett D. Allison, Victor K. Phuong, Laura C. McAtee, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetPharmaceutical Science1000-Fold SelectivityBiochemistry	2006	35
Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt David A. Kummer, Maxwell D. Cummings, M.C. Abad, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryNatural SciencesMolecular Biology	2017	25

Page 1